Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 3
2007 6
2008 4
2009 7
2010 4
2011 8
2012 14
2013 12
2014 15
2015 19
2016 23
2017 19
2018 26
2019 36
2020 52
2021 66
2022 69
2023 78
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean junxia li (205 results)?
Macrophage Polarization and Its Role in Liver Disease.
Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Wang C, et al. Among authors: li y. Front Immunol. 2021 Dec 14;12:803037. doi: 10.3389/fimmu.2021.803037. eCollection 2021. Front Immunol. 2021. PMID: 34970275 Free PMC article. Review.
Gut Microbiota and Diarrhea: An Updated Review.
Li Y, Xia S, Jiang X, Feng C, Gong S, Ma J, Fang Z, Yin J, Yin Y. Li Y, et al. Front Cell Infect Microbiol. 2021 Apr 15;11:625210. doi: 10.3389/fcimb.2021.625210. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33937093 Free PMC article. Review.
Establishment of bovine expanded potential stem cells.
Zhao L, Gao X, Zheng Y, Wang Z, Zhao G, Ren J, Zhang J, Wu J, Wu B, Chen Y, Sun W, Li Y, Su J, Ding Y, Gao Y, Liu M, Bai X, Sun L, Cao G, Tang F, Bao S, Liu P, Li X. Zhao L, et al. Among authors: li y. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2018505118. doi: 10.1073/pnas.2018505118. Proc Natl Acad Sci U S A. 2021. PMID: 33833056 Free PMC article.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: li y. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
426 results